Search - tctmd.com

Displaying 61 - 80 of 237

Sort: Relevancy | Date

Presentation TCT 2018

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

Presenter: Fernando Alfonso, Azeem Latib, Bruno Scheller

September 22, 2018

Presentation TCT 2018

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Presenter: Fernando Alfonso, Azeem Latib

September 22, 2018

Presentation TCT 2018

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Presenter: Fernando Alfonso, Azeem Latib, Antonio Colombo

September 22, 2018

Presentation TCT 2018

Case Study: Mechanism and Treatment of Stent Thrombosis

Presenter: Fernando Alfonso, Azeem Latib, Hiram G. Bezerra, Michael J. Cowley, Kevin J. Croce, Lisette Okkels Jensen, Ashish Pershad, Jose M. de la Torre Hernandez

September 22, 2018

Presentation TCT 2018

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Presenter: Fernando Alfonso, Azeem Latib, Robert A. Byrne

September 22, 2018

Presentation TCT 2018

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Presenter: Renu Virmani, Clemens von Birgelen, Michael Joner

September 22, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Presenter: Ron Waksman

May 05, 2018

Presentation TCT 2017

Case #11 (With Discussion): Late Stent Thrombosis Secondary to Neoatherosclerosis

Presenter: Akiko Maehara, Jose M. de la Torre Hernandez, Joost Daemen

November 01, 2017

Presentation TCT 2017

State-of-the-Art Review: Intravascular Imaging and Physiology to Evaluate Stent Thrombosis and Restenosis

Presenter: Akiko Maehara, Jose M. de la Torre Hernandez, Giulio Guagliumi

November 01, 2017

Presentation TCT 2017

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Presenter: Dean J. Kereiakes, Spencer B. King III, Aloke V. Finn

October 30, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

Presentation iASSESS 2017

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

Presenter: Rajesh V. Swaminathan, Dmitriy N. Feldman

August 30, 2017

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

Presentation

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

July 28, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation Fellows 2017

Stent Thrombosis and Restenosis

Presenter: Emmanouil S. Brilakis, Ajay J. Kirtane

April 08, 2017

Presentation JIM 2017

The EluNIR clinical program: BIONICS and NIREUS - One Year Follow Up

Presenter: Giuseppe Musumeci

February 09, 2017

Presentation TCT 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Advertisement

Are Drug-Coated Balloons Acceptable or Preferred for Stent-Eligible Small Coronary Arteries? Insights From BASKET-SMALL 2 and Other Experiences

POBA, Drug-Coated Balloons, DES and BRS for DES ISR: Advantages, Disadvantages Theory and Evidence

Options for Stent Under-Expansion With ISR: Laser, Stentablation, and More

Case Study: Mechanism and Treatment of Stent Thrombosis

Is There a Standard Work-Up for Stent Thrombosis? Hematology, Imaging, and More

Keynote: Why Do Contemporary DES Fail (Early and Late, Restenosis and Thrombosis)?

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Case #11 (With Discussion): Late Stent Thrombosis Secondary to Neoatherosclerosis

State-of-the-Art Review: Intravascular Imaging and Physiology to Evaluate Stent Thrombosis and Restenosis

New Insights Into Neoatherosclerosis and Other Causes of Metallic Stent Thrombosis: Will the Most Dreaded Complication Always Be With Us?

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

New Generation Drug Eluting Stents & Bioabsorbable Vascular Scaffolds: Indications, Outcomes, & Complications

STEMI: Treatment Strategies, Drugs And Devices

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

Stent Thrombosis and Restenosis

The EluNIR clinical program: BIONICS and NIREUS - One Year Follow Up

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content